HEPA
Price:
$0.7244
Market Cap:
$4.20M
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The co...[Read more]
Industry
Biotechnology
IPO Date
2014-02-10
Stock Exchange
NASDAQ
Ticker
HEPA
According to Hepion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.24M. This represents a change of 148.40% compared to the average of 901.76K of the last 4 quarters.
The mean historical Enterprise Value of Hepion Pharmaceuticals, Inc. over the last ten years is 10.98M. The current 2.24M Enterprise Value has changed 1.94% with respect to the historical average. Over the past ten years (40 quarters), HEPA's Enterprise Value was at its highest in in the March 2017 quarter at 105.91M. The Enterprise Value was at its lowest in in the December 2022 quarter at -28266594.00.
Average
10.98M
Median
262.77K
Minimum
-28266642.00
Maximum
105.93M
Discovering the peaks and valleys of Hepion Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 767.95%
Maximum Annual Enterprise Value = 105.93M
Minimum Annual Increase = -196.73%
Minimum Annual Enterprise Value = -28266642.00
Year | Enterprise Value | Change |
---|---|---|
2023 | -1711435.60 | -93.95% |
2022 | -28266642.00 | 159.34% |
2021 | -10899642.20 | -41.96% |
2020 | -18780246.20 | 767.95% |
2019 | -2163758.60 | -196.73% |
2018 | 2.24M | -89.79% |
2017 | 21.92M | 5.27% |
2017 | 20.82M | 0.36% |
2016 | 20.75M | -80.41% |
2015 | 105.93M | 753.96% |
The current Enterprise Value of Hepion Pharmaceuticals, Inc. (HEPA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-13625906.60
5-year avg
-12364344.92
10-year avg
10.98M
Hepion Pharmaceuticals, Inc.’s Enterprise Value is greater than Enveric Biosciences, Inc. (1.02M), greater than CohBar, Inc. (-4942363.00), less than Elevation Oncology, Inc. (8.41M), less than Ocean Biomedical, Inc. (44.98M), greater than AVROBIO, Inc. (-85302404.00), less than Zura Bio Limited (42.42M), less than eFFECTOR Therapeutics, Inc. (3.83M),
Company | Enterprise Value | Market cap |
---|---|---|
1.02M | $4.53M | |
-4942363.00 | $1.25M | |
8.41M | $36.94M | |
44.98M | $33.96M | |
-85302404.00 | $5.24M | |
42.42M | $230.86M | |
3.83M | $188.18K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hepion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hepion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hepion Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the 3-year average Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the 5-year average Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA)?
How does the current Enterprise Value for Hepion Pharmaceuticals, Inc. (HEPA) compare to its historical average?